Form 4: TransMedics CFO Sells Shares for Tax Obligations

TransMedics Group's CFO, Gerardo Hernandez, sold 920 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Gerardo Hernandez, Chief Financial Officer of TransMedics Group, Inc., reported a transaction involving the company's common stock.
• On December 4, 2025, Mr. Hernandez sold 920 shares of TransMedics Group, Inc. common stock.
• The shares were sold at a price of $139.62 per share.
• The total value of the shares sold is approximately $128,450.40.
• The sale was conducted to satisfy tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• This "sell to cover" transaction was made pursuant to the terms of the RSU award and was part of a pre-arranged plan under Rule 10b5-1(c).
• Following this transaction, Mr. Hernandez beneficially owns 15,064 shares of TransMedics Group, Inc. common stock.

Sentiment

Score: 5

Explanation: The transaction is a standard "sell to cover" to satisfy tax obligations upon RSU vesting, which is a common and expected event for executives. It does not reflect a discretionary decision to sell shares based on company performance or outlook.

Positives

• The transaction was a routine "sell to cover" to meet tax obligations, indicating a planned and non-discretionary sale rather than a discretionary divestment.
• The sale was executed under a Rule 10b5-1(c) plan, suggesting a pre-scheduled transaction designed to avoid accusations of insider trading.

Negatives

• A reduction in direct beneficial ownership by a key executive, even if for tax purposes, slightly decreases management's direct equity alignment with shareholders.

Future Outlook

NA

Industry Context

This transaction is a routine insider filing common across all industries when executives' restricted stock units vest, requiring a portion of shares to be sold to cover tax liabilities. It does not reflect specific industry trends or competitive positioning.

Comparison to Industry Standards

• Routine 'sell to cover' transactions for tax purposes are standard practice for executives across publicly traded companies, including those in the medical device and biotechnology sectors.
• This type of transaction is not indicative of a company's performance relative to peers but rather a common mechanism for managing equity compensation.

Stakeholder Impact

• Shareholders: A very minor, routine dilution of ownership due to the sale of shares, but generally considered neutral as it's for tax purposes and not a discretionary sale.
• Employees: No direct impact on employees beyond the reporting person.

Key Dates

Recommendation

This Form 4 reports a routine "sell to cover" transaction by the CFO to satisfy tax obligations upon RSU vesting. Such transactions are common, pre-planned under Rule 10b5-1(c), and generally do not reflect a change in management's confidence or the company's fundamentals. Therefore, it provides no new information that would warrant a change in investment recommendation. Investors should continue to hold based on broader company performance and market conditions.

Keywords

TransMedics Group, TMDX, Gerardo Hernandez, CFO, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Obligations, Sell to Cover, 10b5-1 Plan